Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meredith B Rosenthal

Showing results (1-10 of 187) with videos related to

Pageof 19
Sort By:
The New England Journal of Medicine|April 22, 2011
Hard choices--alternatives for reining in Medicare and Medicaid spendingMeredith B Rosenthal
JAMA|July 17, 2023
Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement PolicyMeredith B Rosenthal
BMJ (Clinical Research Ed.)|October 30, 2024
Healthcare affordability and the 2024 US presidential election-real change still seems unlikelyMeredith B Rosenthal
Health Affairs (Project Hope)|November 13, 2004
Doughnut-hole economicsMeredith B Rosenthal
The American Journal of Managed Care|May 10, 2007
P4P: rumors of its demise may be exaggeratedMeredith B Rosenthal
The Virtual Mentor : VM|December 11, 2012
Avoiding Disincentives to Treat in Designing Pay-for-Performance MeasuresMeredith B Rosenthal
The New England Journal of Medicine|May 22, 2009
What works in market-oriented health policy?Meredith B Rosenthal
The New England Journal of Medicine|September 19, 2008
Beyond pay for performance--emerging models of provider-payment reformMeredith B Rosenthal
The Virtual Mentor : VM|December 13, 2012
How will paying for performance affect patient care?Meredith B Rosenthal
The New England Journal of Medicine|October 19, 2007
Nonpayment for performance? Medicare's new reimbursement ruleMeredith B Rosenthal
Pageof 19

Showing results (1-10 of 187) with videos related to

Sort By:
Pageof 19
The New England Journal of Medicine|April 22, 2011
Hard choices--alternatives for reining in Medicare and Medicaid spendingMeredith B Rosenthal
JAMA|July 17, 2023
Novel Alzheimer Disease Treatments and Reconsideration of US Pharmaceutical Reimbursement PolicyMeredith B Rosenthal
BMJ (Clinical Research Ed.)|October 30, 2024
Healthcare affordability and the 2024 US presidential election-real change still seems unlikelyMeredith B Rosenthal
Health Affairs (Project Hope)|November 13, 2004
Doughnut-hole economicsMeredith B Rosenthal
The American Journal of Managed Care|May 10, 2007
P4P: rumors of its demise may be exaggeratedMeredith B Rosenthal
The Virtual Mentor : VM|December 11, 2012
Avoiding Disincentives to Treat in Designing Pay-for-Performance MeasuresMeredith B Rosenthal
The New England Journal of Medicine|May 22, 2009
What works in market-oriented health policy?Meredith B Rosenthal
The New England Journal of Medicine|September 19, 2008
Beyond pay for performance--emerging models of provider-payment reformMeredith B Rosenthal
The Virtual Mentor : VM|December 13, 2012
How will paying for performance affect patient care?Meredith B Rosenthal
The New England Journal of Medicine|October 19, 2007
Nonpayment for performance? Medicare's new reimbursement ruleMeredith B Rosenthal
Pageof 19